1.07
0.93%
+0.00
ABVC BioPharma Inc Aktie (ABVC) Neueste Nachrichten
ABVC BioPharma (NASDAQ:ABVC) Issues Earnings Results - Defense World
Defense World
Biotech Innovations Drive Hope in Global Fight Against Pancreatic Cancer - Baystreet.ca
Baystreet.ca
ABVC BioPharma, Inc. (NASDAQ:ABVC) Short Interest Update - Defense World
Defense World
Get in on ABVC BioPharma Inc's (ABVC) buy-in window today! – Sete News - SETE News
SETE News
Attention Deficit Hyperactivity Disorder Market and Epidemiology 2032: Treatment Market, Therapies, Companies, FDA ... - Barchart
Barchart
Why Tesla Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket - ABVC BioPharma (NA - Benzinga
Benzinga
ABVC BioPharma's AiBtl BioPharma acquires TT Life Company - TipRanks.com - TipRanks
TipRanks
AiBtl BioPharma Inc. Acquired TT Life Company, Valued at $8.33M, With 1.66M AiBtl Shares at $5 per Share
GlobeNewswire Inc.
AiBtl BioPharma Inc. Acquired TT Life Company, Valued at $8.33 M, With 1.66 M AiBtl Shares at $5 per Share - GlobeNewswire
GlobeNewswire
ABVC BioPharma Executes a Global Licensing Definitive Agreement for the Treatment of NSCLC, Expecting Aggregate ... - GlobeNewswire
GlobeNewswire
ABVC BioPharma inks $105M Oncology/Hematology deal - Investing.com ZA - Investing.com South Africa
Investing.com South Africa
ABVC BioPharma Entered into a Global Licensing Deal of Vitargus with Licensing Income of $33.5M and Royalties up to $60M
GlobeNewswire Inc.
ABVC BioPharma Entered into a Global Licensing Deal of Vitargus with Licensing Income of $33.5M and Royalties up ... - GlobeNewswire
GlobeNewswire
AiBtl BioPharma Inc. Completes $7.6M Land Deal: Exchanging Stock for Real Estate, Demonstrating the Value of ... - Yahoo Finance
Yahoo Finance
ABVC BioPharma, Inc. CEO Selected as 2024 Top 10 CEO in CEO Insights Asia Magazine - GlobeNewswire
GlobeNewswire
ABVC BioPharma Reports Annual 2023 Financials and Provides Fiscal Year 2024 First Quarter Business Update
GlobeNewswire Inc.
ABVC Stock Quote Price and Forecast - CNN
CNN
ABVC BioPharma Executes a Definitive Agreement to Receive License Fees of $3M and Royalties of 2% on Future ... - Yahoo Finance
Yahoo Finance
ABVC BioPharma Receives Australian Patent, Valid Until 2040, for Its Treatment of Major Depressive Disorder (MDD) - Yahoo Finance
Yahoo Finance
ABVC Acquires $2.96 Million Worth of Land in Asia with Stocks Priced at $3.50 per Share
GlobeNewswire Inc.
ABVC Acquires $2.96 Million Worth of Land in Asia with Stocks Priced at $3.50 per Share - GlobeNewswire
GlobeNewswire
Why Mobileye Global Shares Are Trading Lower By Over 23%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Benzinga
Why Resources Connection Shares Are Trading Higher By Over 6%; Here Are 20 Stocks Moving Premarket
Benzinga
Why Mobileye Global Shares Are Trading Lower By Over 23%? Here Are Other Stocks Moving In Thursday’s Mid- - Benzinga
Benzinga
Why SoFi Technologies Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Benzinga
ABVC BioPharma and its Subsidiary Receive $460M From AiBtl BioPharma as the First Milestone Payment of Global Licensing Fees
GlobeNewswire Inc.
Why SoFi Technologies Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Wednesday’s - Benzinga
Benzinga
ABVC BioPharma Announces Completion of Subject Treatment for Interim Analysis on ADHD Phase IIb Clinical Study
GlobeNewswire Inc.
Why American Eagle Shares Are Trading Lower By Around 16%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Benzinga
US Stocks Down; Chicago Fed National Activity Index Falls In October
Benzinga
ABVC BioPharma Receives U.S. Patent for ADHD Treatment, a $32 Billion Market
GlobeNewswire Inc.
Why American Eagle Shares Are Trading Lower By Around 16%? Here Are Other Stocks Moving In Tuesday’s Mid- - Benzinga
Benzinga
AiBtl signs $667m licensing deal for ABVC’s CNS drug - Pharmaceutical Technology
Pharmaceutical Technology
ABVC BioPharma Enters Definitive Agreement with Licensing Income Worth $467M and Royalties Up to $200M - Yahoo Finance
Yahoo Finance
ABVC BioPharma Reports Third Quarter 2023 Financial and Operational Results - GlobeNewswire
GlobeNewswire
Best Penny Stocks To Buy Now? 3 Biotech Stocks To Watch - Penny Stocks
Penny Stocks
ABVC BioPharma Announces Reverse Stock Split - Yahoo Finance
Yahoo Finance
ABVC BioPharma, Inc. Announces New CEO as It Targets Further Growth - Yahoo Finance
Yahoo Finance
ABVC BioPharma Provides Vitargus Update on Phase II Site Initiation Visit Conducted at Ramathibodi Hospital in ... - GlobeNewswire
GlobeNewswire
ABVC BioPharma Provides Vitargus® Update on Phase II Site Initiation Visit Conducted at Srinagarind Hospital in ... - PR Newswire
PR Newswire
ABVC BioPharma Receives $3.175 Million Investment From The Lind Partners to Continue Clinical Trials - GlobeNewswire
GlobeNewswire
ABVC Biopharma on the path to validating traditional medicine for the modern world - BioWorld Online
BioWorld Online
ABVC BioPharma ABV-1505 ADHD Phase IIa Results Presented at 2023 APSARD Conference - GlobeNewswire
GlobeNewswire
FDA Approves IND Submission Allowing ABVC BioPharma to Proceed With Clinical Study of ABV-1519 for Treatment ... - GlobeNewswire
GlobeNewswire
ABVC Provides Oncology Pipeline Updates - GlobeNewswire
GlobeNewswire
ABVC BioPharma Expands Co-Development Partnership With Rgene Corporation - GlobeNewswire
GlobeNewswire
ABVC BioPharma Inc. (NASDAQ: ABVC) Receives Approval From Taiwan Central Institution Review Board For ABV ... - BP Journal
BP Journal
ABVC Biopharma cools off following meme buzz; shares fall 33% - Seeking Alpha
Seeking Alpha
ABVC BioPharma (ABVC) Stock Price, News & Analysis - MarketBeat
MarketBeat
ABVC Stock Price and Chart — NASDAQ:ABVC — TradingView - TradingView
TradingView
Kapitalisierung:
|
Volumen (24h):